Moreover, in a gene expression study of breast cancer patients, MRCKα, alias PK428, was identified as part of a profile of 70 genes predicting short interval to metastasis formation and poor prognosis [13]. The gene discussed is CDC42BPA; the disease is breast carcinoma.